These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol. Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ BMJ Open; 2019 Jan; 9(1):e023736. PubMed ID: 30782714 [TBL] [Abstract][Full Text] [Related]
26. Haemodiafiltration does not reduce the frequency of intradialytic hypotensive episodes when compared to cooled high-flux haemodialysis. Pinney JH; Oates T; Davenport A Nephron Clin Pract; 2011; 119(2):c138-44. PubMed ID: 21757951 [TBL] [Abstract][Full Text] [Related]
27. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study. Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319 [TBL] [Abstract][Full Text] [Related]
28. Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA. Mac K; Hedley J; Kelly PJ; Lee VW; Agar JWM; Hawley CM; Johnson DW; See EJ; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC Nephrology (Carlton); 2020 Jan; 25(1):63-72. PubMed ID: 30838737 [TBL] [Abstract][Full Text] [Related]
29. Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study. Jean G; Hurot JM; Deleaval P; Mayor B; Lorriaux C BMC Nephrol; 2015 May; 16():70. PubMed ID: 25956949 [TBL] [Abstract][Full Text] [Related]
30. Super high-flux hemodialysis provides comparable effectiveness with high-volume postdilution online hemodiafiltration in removing protein-bound and middle-molecule uremic toxins: A prospective cross-over randomized controlled trial. Thammathiwat T; Tiranathanagul K; Limjariyakul M; Chariyavilaskul P; Takkavatakarn K; Susantitaphong P; Meesangnin S; Wittayalertpanya S; Praditpornsilpa K; Eiam-Ong S Ther Apher Dial; 2021 Feb; 25(1):73-81. PubMed ID: 32356365 [TBL] [Abstract][Full Text] [Related]
31. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Schiffl H Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355 [TBL] [Abstract][Full Text] [Related]
32. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration. Jansz TT; Özyilmaz A; Grooteman MPC; Hoekstra T; Romijn M; Blankestijn PJ; Bots ML; van Jaarsveld BC BMJ Open; 2018 Mar; 8(3):e019900. PubMed ID: 29523566 [TBL] [Abstract][Full Text] [Related]
33. High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode. Schiffl H Int Urol Nephrol; 2020 Aug; 52(8):1501-1506. PubMed ID: 32488753 [TBL] [Abstract][Full Text] [Related]
34. Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: A randomized cross-over trial. Kurtkoti J; Bose B; Hiremagalur B; Sun J; Cochrane T Nephrology (Carlton); 2016 Aug; 21(8):663-8. PubMed ID: 26609786 [TBL] [Abstract][Full Text] [Related]
35. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients. Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937 [TBL] [Abstract][Full Text] [Related]
36. Improvement of clinical outcomes in dialysis: No convincing superiority in dialysis efficacy using hemodiafiltration vs high-flux hemodialysis. Abdelsalam M; Demerdash TM; Assem M; Awais M; Shaheen M; Sabri A; Alanany H; Kashgary A; Alsuwaida A Ther Apher Dial; 2021 Aug; 25(4):483-489. PubMed ID: 32243070 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Vilar E; Fry AC; Wellsted D; Tattersall JE; Greenwood RN; Farrington K Clin J Am Soc Nephrol; 2009 Dec; 4(12):1944-53. PubMed ID: 19820129 [TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
39. Haemodiafiltration use in children: data from the Italian Pediatric Dialysis Registry. Paglialonga F; Vidal E; Pecoraro C; Guzzo I; Giordano M; Gianoglio B; Corrado C; Roperto R; Ratsch I; Luzio S; Murer L; Consolo S; Pieri G; Montini G; Edefonti A; Verrina E Pediatr Nephrol; 2019 Jun; 34(6):1057-1063. PubMed ID: 30612203 [TBL] [Abstract][Full Text] [Related]
40. Cost comparison of online haemodiafiltration with high-flux haemodialysis. Oates T; Cross J; Davenport A J Nephrol; 2012; 25(2):192-7. PubMed ID: 22038334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]